| Bioactivity | Ribociclib acetate is a degradation product of Ribociclib (HY-15777) under acid-base hydrolysis conditions. Ribociclib acetate has been predicted to be carcinogenic[1]. |
| CAS | 2762182-61-4 |
| Formula | C21H25N7O2 |
| Molar Mass | 407.47 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Sahu AK, et al. Identification and structural characterization of potential degraded impurities of ribociclib by time of flight -tandem mass spectrometry, and their toxicity prediction. J Pharm Biomed Anal. 2021 Apr 15;197:113933. |
Ribociclib acetate
CAS: 2762182-61-4 F: C21H25N7O2 W: 407.47
Ribociclib acetate is a degradation product of Ribociclib (HY-15777) under acid-base hydrolysis conditions. Ribociclib a
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.